Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference104 articles.
1. Androgen receptor action in hormone-dependent and recurrent prostate cancer;Agoulnik;J. Cell. Biochem.,2006
2. Cabazitaxel remains active in patients progressing after docetaxel followed by novel androgen receptor pathway targeted therapies;Al Nakouzi;Eur. Urol.,2015
3. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J. Clin. Oncol.,2009
4. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer;Antonarakis;N. Engl. J. Med.,2014
5. AR-V7 splice variant and resistance to enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC): overall survival results;Antonarakis;Ann. Oncol.,2014
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy;Journal of Urologic Oncology;2023-11-30
2. What should be the future direction of development in the field of prostate cancer with lung metastasis?;World Journal of Clinical Oncology;2023-10-24
3. The Crucial Role of AR-V7 in Enzalutamide-Resistance of Castration-Resistant Prostate Cancer;Cancers;2022-10-05
4. Ilicicolin A Exerts Antitumor Effect in Castration-Resistant Prostate Cancer Via Suppressing EZH2 Signaling Pathway;Frontiers in Pharmacology;2021-10-27
5. Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort;British Journal of Cancer;2019-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3